| Alcoholic liver disease–pathophysiological aspects and risk factors A Gramenzi, F Caputo, M Biselli, F Kuria, E Loggi, P Andreone, ... Alimentary pharmacology & therapeutics 24 (8), 1151-1161, 2006 | 268 | 2006 |
| The MELD score in patients awaiting liver transplant: strengths and weaknesses M Bernardi, S Gitto, M Biselli Journal of hepatology 54 (6), 1297-1306, 2011 | 211 | 2011 |
| Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis M Domenicali, M Baldassarre, FA Giannone, M Naldi, M Mastroroberto, ... Hepatology 60 (6), 1851-1860, 2014 | 167 | 2014 |
| New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm M Renzulli, M Biselli, S Brocchi, A Granito, F Vasuri, F Tovoli, ... Gut 67 (9), 1674-1682, 2018 | 156 | 2018 |
| Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience GF Stefanini, P Amorati, M Biselli, F Mucci, A Celi, V Arienti, R Roversi, ... Cancer 75 (10), 2427-2434, 1995 | 139 | 1995 |
| Posttransplantation lymphoproliferative disorders P Andreone, A Gramenzi, S Lorenzini, M Biselli, C Cursaro, S Pileri, ... Archives of internal medicine 163 (17), 1997-2004, 2003 | 128 | 2003 |
| Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation F Piscaglia, A Gianstefani, M Ravaioli, R Golfieri, A Cappelli, ... Liver Transplantation 16 (5), 658-667, 2010 | 126 | 2010 |
| Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection A Gramenzi, P Andreone, E Loggi, FG Foschi, C Cursaro, M Margotti, ... Journal of viral hepatitis 12 (5), 525-530, 2005 | 118 | 2005 |
| In vitro effect of thymosin‐α1 and interferon‐α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C P Andreone, C Cursaro, A Gramenzi, M Margotti, E Ferri, S Talarico, ... Journal of Viral Hepatitis 8 (3), 194-201, 2001 | 107 | 2001 |
| High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo … S Berardi, F Lodato, A Gramenzi, A D’Errico, M Lenzi, A Bontadini, ... Gut 56 (2), 237-242, 2007 | 106 | 2007 |
| Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial P Andreone, S Fiorino, C Cursaro, A Gramenzi, M Margotti, ... Antiviral research 49 (2), 75-81, 2001 | 103 | 2001 |
| Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system E Raschi, E Poluzzi, A Koci, F Salvo, A Pariente, M Biselli, U Moretti, ... British journal of clinical pharmacology 80 (2), 285-293, 2015 | 96 | 2015 |
| A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis M Biselli, F Conti, A Gramenzi, M Frigerio, A Cucchetti, G Fatti, M D'angelo, ... British journal of cancer 112 (1), 69-76, 2015 | 93 | 2015 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 92 | 2017 |
| A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma G Cabibbo, S Petta, M Barbàra, G Missale, R Virdone, E Caturelli, ... Liver International 37 (8), 1157-1166, 2017 | 87 | 2017 |
| Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? M Biselli, S Gitto, A Gramenzi, R Di Donato, L Brodosi, M Ravaioli, ... Liver transplantation 16 (8), 964-973, 2010 | 83 | 2010 |
| Update on the mechanisms of liver regeneration ME Preziosi, SP Monga Seminars in liver disease 37 (02), 141-151, 2017 | 80 | 2017 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 80 | 2017 |
| QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis F Trevisani, A Di Micoli, A Zambruni, M Biselli, V Santi, V Erroi, B Lenzi, ... Liver International 32 (10), 1510-1515, 2012 | 74 | 2012 |
| Application of the intermediate-stage subclassification to patients with untreated hepatocellular carcinoma EG Giannini, A Moscatelli, G Pellegatta, A Vitale, F Farinati, F Ciccarese, ... Official journal of the American College of Gastroenterology| ACG 111 (1), 70-77, 2016 | 73 | 2016 |
